ArticleFrontiers in veterinary science2026
Papillomavirus is not detected in benign neoplasms of the canine Meibomian gland despite evidence of HPV-mediated tumorigenesis in the human Meibomian gland.
Article in Frontiers in veterinary science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Objective: Meibomian gland (MG) tumors are common in dogs. Papillomaviruses have been detected in epithelial neoplasms across species, including those arising from the human MG, but their role in the development of canine MG tumors has not been investigated. The purpose of this study was to evaluate whether Canine Papillomavirus (CPV) contributes to MG tumorigenesis. Methods: A retrospective review of a Laboratory Information Management System (LIMS) was performed to identify cases of canine MG tumors submitted between 2019 and 2024. DNA was extracted from archival FFPE tissue scrolls, and PCR was performed using validated viral CPV-1 E6 and L1 primers. Clinicopathologic features including patient age and sex, tumor size, tumor laterality and location, presence of chalazion, mitotic count, and extent of surgical excision were evaluated. Results: LIMS review yielded 106 cases of canine MG tumors, and 102 were histologically confirmed to be MG adenomas or epitheliomas. PCR was performed on 99 samples, and no viral amplicons were detected in any MG tumor. Dogs with adenomas were younger than those with epitheliomas. There were no differences in sex or alteration status between tumor groups, and Labrador retrievers and Poodles were overrepresented. There were no differences between tumor types in terms of laterality or upper vs. lower eyelid. Adenomas were smaller and had lower mitotic counts compared to epitheliomas. The presence of chalazion or completeness of the surgical excision was not different between tumor subtypes. Conclusion: While we confirm consistent morphologic and phenotypic differences between canine MG adenomas and epitheliomas, these results suggest that, unlike their human counterparts, neither tumor subtype is virally mediated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.